by ascendketamine | Jul 7, 2018 | Uncategorized
Ketamine is a revolutionary and powerful drug used to help patients suffering from treatment-resistant depression; with this in mind researchers are now looking at the way we treat depression and other psychiatric disorders from a different perspective. The success of... 
by ascendketamine | Jun 24, 2018 | Uncategorized
There are about 41,000 suicides reported each year in the US—many of which are the result of poorly treated or treatment-resistant depression (TRD). Esketamine, an isomer of ketamine which is being researched and developed by Jannsen Pharmaceuticals, would become one... 
by ascendketamine | Jun 15, 2018 | Uncategorized
A ketamine infusion is used to treat a variety of mental health disorders, including—but not limited to: depression, anxiety, PTSD, bipolar disorder, and chronic pain. Everyone responds differently to psychiatric medications, and for some, pharmacological solutions... 
by ascendketamine | May 19, 2018 | Uncategorized
Opiates—highly addictive, widely used, and trusted by medical professionals to relieve the symptoms of acute pain. While highly effective, do we ever stop to consider whether these narcotics are doing more harm than good? Opioid addiction is exponentially increasing... 
by ascendketamine | May 8, 2018 | Uncategorized
The on-going debate of nature vs. nurture is widespread, and applicable to a variety of topics. The nature concept is the idea that some individuals are born more susceptible to mental health issues based on their genetic make-up. Nurture is the notion that implies... 
by ascendketamine | Apr 26, 2018 | Uncategorized
Awarded “breakthrough” status by the FDA back in 2016, clinical trials continue to show promise for Johnson & Johnson’s esketamine—an isomer of ketamine that is administered intranasally. Just this week, the American Journal of Psychiatry (AJP) published the...
Recent Comments